Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2025.Nov.10

Announcement of BOD’s resolution to lift the non-competition restrictions for managerial officers

2025.Nov.10

Announcement that the cumulative reduction of shareholding in major subsidiary, OBIGEN Pharma, has reached more than 10%

2025.Nov.10

Announcement of Change in the Company’s Certified Public Accountant Due to Internal Adjustment of the Accounting Firm

2025.Nov.10

Announcement of the Consolidated Financial Statements for the third quarter of 2025 were approved by the Board of Directors

2025.Oct.31

Announcement for the expected date of the Board of Directors Meeting for 2025Q3 consolidated financial report is 2025/11/10

2025.Oct.20

Announcement to creditors of the Company for conducting capital reduction to make up for losses.

2025.Oct.20

Announcement of the Company’s important resolutions of the 2025 First Extraordinary General Shareholders’ meeting.

2025.Oct.17

Announcement on behalf of OBIGEN that it obtains the Internal Control Special Audit Report by CPA

2025.Oct.02

Announcement on behalf of Obigen’s BOD to resolve the reference date for conversion of employee stock options to common shares

2025.Sep.01

Press Conference on Material Information Regarding the Board Resolution for Capital Reduction to Offset Accumulated Losses

News

Latest News

Events

Latest events